Quantcast
Close Window
   
Welcome :o)
If healthcare, consumer and food products were safe, we wouldn't need a healthcare industry ;o)
 
or the FDA, CDC, ACA, NIH, etc...
 
Now THAT sure would save a shit-load of money, wouldn't it ;o)
HomeAbout

Content List
100+ articles of harm and corruption by Johnson & Johnson and subsidiary products.
Click for content list...

Hi All,
This is INDEPENDENT, AD-FREE work that you are certainly NOT going to see in conventional media.
 
Please help keep JohnsonAndToxin ad-free, online and me working to expose Johnson & Johnson and their 275+ subsidiaries for the benefit of every man, woman and child on the planet - and that INCLUDES YOU.
 
Thank you,   
Emily
 
$.00         
Glad to see you :o)
Hi All,
This is INDEPENDENT work that you are certainly NOT going to see in conventional media.
Gifts of support are always very much appreciated...
 
Thank you,
Emily
 
$.00         

Notable visitors to the web site include:
 
US GOVERNMENT:
United States Air Force
US Senate
US Department of Defense
US Department of Justice
US Homeland Security
US Centers for Disease Control
 
GLOBAL FINANCIAL INSTITUTIONS:
Vanguard
Barclays
The Bank of New York Mellon Corp
Lloyds Banking Group PLC
Royal Bank of Canada
Bank of America
Harris Trust & Savings Bank
Deutsche Bank
Macquarie Bank
PNC Bank
Crédit Agricole Bank
Royal Bank of Scotland
Raymond James Financial
BlackRock Financial Management
...and many, many more from all over the world ;o)
 
Feel free to browse list of notable visitors to the web site.
 
Sponsored in part by...
Risperdal Boys Project Undisclosed to patients, Risperdal causes breast growth in boys.
----- / / -----
Examining Medicine An in-depth comprehensive, frequently updated look at extreme risks and permanent brain damage caused by psychiatric drugs.
----- / / -----
Fiddaman Blog Bob Fiddaman has been writing about the dangers of antidepressants since 2006. In 2011 he was presented with two human rights awards from the Citizens Commission on Human Rights.
----- / / -----
Special Needs Advocate Power Join me as we work hard to ensure what our very special children need.

Johnson & Johnson Begs US FDA to Expand Xarelto Slaughter
After killing around 2,000 people in the United States in 2016 alone, Johnson & Johnson wants to spread the deaths even more!

Keywords: xarelto, death, dead, lawsuit, fda, litigation, bleed, aspirin
Date Created/Edited: September 4, 2017
 

Most Recent Content....
History of Johnson & Johnson Janssen Fentanyl
Hmm, looks like Johnson & Johnson is profiting from BOTH sides of opioid addiction crisis ;o)
 
15 Steps to Solve Healthcare Crisis
How about this for a rough outline of a strategy to dramatically reduce healthcare costs?
 
ACA the Affordable CORRUPTION Act
The only purpose of the ACA/ObamaCare was to force everyone to pay legal fees and victim settlements and care from harm by Johnson & Johnson.
 
Johnson & Johnson Begs US FDA to Expand Xarelto Slaughter
After killing around 2,000 people in the United States in 2016 alone, Johnson & Johnson wants to spread the deaths even more!
 
Johnson & Johnson Facing Over $100 BILLION in Lawsuit Debt
With a flood of lawsuits pouring in from around the world, Johnson & Johnson is facing at least $100 BILLION lawsuit debt.
 
The Johnson & Johnson Drugged Kids Pension Plan
Teacher and state retirement funds invest in Johnson & Johnson, the DRUGGED KIDS PENSION PLAN
 
Second Quarter 2017 Lawsuits Against Johnson & Johnson
Lawsuits against Johnson & Johnson in United States holding at 106,600! DOES NOT INCLUDE ALL PRODUCTS FACING LAWSUITS OR LAWUITS FILED OUTSIDE THE UNITED STATES!
 
Special Sections....
Mesh Files
Baby Powder (talc) Files
Risperdal Files
Levaquin Files
Xarelto Files
Hips Files
Letters to Shareholders
SEC Lawsuits Files

 
Recent Content....
Why President Trump Should Shut Down US FDA (2017, March 28)
Healthcare organizations around the world depend on US FDA decisions, however, profit, rather than safety, seems to be the primary motivation.
healthcare, health, obamacare, donald, trump, fda, fraud, kickback
 
The Difference Between Guinea Pig and Cash Cow (2016, September 27)
People keep saying pharma is using us as 'guinea pigs'. Uh, not quite. Take a minute to learn the difference between a 'guinea pig' and a 'cash cow'.
guinea pig, immunization, vaccination, profit, harm, autism, disability, asthma
 
Johnson & Johnson Victims at Risk of RE-Victimization (2016, August 22)
If you are currently a victim of a known harmful Johnson & Johnson subsidiary product and have high medical needs due to your injuries, you are at increased risk of becoming a victim of another known harmful Johnson & Johnson subsidiary product.
jnj, johnson and johnson, johnson & johnson, victim, mesh, hip, levaquin, risperdal
 
Johnson & Johnson Animas Defective Diabetes Devices (2016, August 4)
Gosh and golly gee willikers, yet another Johnson & Johnson subsidiary, Animas, totally sucks, jah?
Johnson and Johnson, Johnson & Johnson, animas, vibe, diabetes, insulin, device, pump
 
Johnson & Johnson Ethicrap, I Mean EthiCON, More JNJ JUNK (2016, July 25)
As I've mentioned, Johnson & Johnson has so many bad products I have to put a bunch in each article now to try to keep up. Now for EthiCON crap.
Johnson and Johnson, Johnson & Johnson, ethicon, harmonic ace, morcellator, physiomesh, secure strap, stapler
 
I first wrote about Xarelto back in May of 2012. At that time, I stated that I thought Xarelto was another overhyped dud. I have definitely been proven correct. My closing paragraph sums up what I thought about Xarelto at that time...
"Missing data, 12% dropout rate (or lost track of) and three deaths should be a sure sign that J&J knows there are issues with the drug. In addition, the expectation of such a large number of recipients to total over a billion in sales, although the drug should not be prescribed to those under 18, over 65, anyone with high blood pressure, etc, as well as the known and published side effects - um, how, exactly, could this be a 'blockbuster'? What I see is more off-label marketing to meet sales goals and more harm with resulting lawsuits. Oh, joy. Higher health care costs to pay for yet another 'blockbuster'. More like 'economy buster'."
A recently published article by Matthew Herper in Forbes explains that Johnson & Johnson wants to push KNOWN HARMFUL Xarelto through the FDA for additional indications - to increase sales by over $1.5 BILLION healthcare dollars. Has everyone at Johnson & Johnson and the United States Food and Drug Administration lost their minds?
 
Most notable about article is:
the 27,395-person trial specifically recruited patients who didn't need these other drugs, and whose disease was stable.
and this...
Bleeding occurred in three patients out of every hundred in the Xarelto plus aspirin arm of the trial, a 70% increase compared to aspirin alone...

 

So, um, they studied only those who don't need drugs because their disease is stable and there is a 70% increase in bleeding. Doesn't sound like a big deal? Hm....
 
Johnson & Johnson has already been accused of false marketing for Xarelto - with over 20,000 lawsuits filed as of second quarter 2017 10-Q.
 
In 2016 alone there were over 15,000 adverse events including approximately 2,000 DEAD from use of Xarelto. That is the equivalent of FIVE PEOPLE DEAD FROM XARELTO EVERY SINGLE DAY. That's a whole lot of bodies, and that is the count only in the United States - with uncountable more bodies dropping from Xarelto in the other 129 countries where it is also sold.
 
And now these FREAKS at $JNJ $BAYR want to INCREASE VICTIMS?
 
As with the original Xarelto trials where the people that DIED were kicked out of study, United States Food and Drug Administration decision will be based solely on a hand-picked subgroup that show some possible benefit, maybe since subgroup already had condition under control, and um, weren't one of the ones that DIED from Xarelto during the study.
 
I don't know about you, but I cannot understand how a drug that KILLS FIVE PEOPLE A DAY is still on the market let alone even considered for MORE PEOPLE!
 
Resources:
1. Emily Patterson (2012, May 23) Xarelto by Johnson & Johnson is Likely Another OverHyped Dud. JohnsonAndToxin Retrieved from http://www.johnsonandtoxin.com/xarelto.shtml
 
2. Matthew Herper (2017, August 27) New Data Could Add $1.5 Billion To Sales Of Johnson & Johnson Blood Thinner. Forbes Retrieved from https://www.forbes.com/sites/matthewherper/2017/08/27/new-data-could-add-1-5-billion-to-sales-of-johnson-johnsonbayer-blood-thinner/
 
3. Emily Patterson (2014, September 14) Johnson & Johnson Xarelto, False Marketing, Lawsuits and FDA Says THREE TIMES, "NO EXPANDED USES!". JohnsonAndToxin Retrieved from http://www.johnsonandtoxin.com/xarelto_continued.shtml
 
4. Emily Patterson (2017, August 8) Second Quarter 2017 Lawsuits Against Johnson & Johnson Stable, BUT NOT All-Inclusive. JohnsonAndToxin Retrieved from http://www.johnsonandtoxin.com/2017_second_quarter_lawsuits.shtml
 
5. Mark Annick (2017, July 25) More than 15,000 Adverse Events Linked to Xarelto in 2016. PR Newswire Retrieved from https://finance.yahoo.com/news/report-more-15-000-adverse-183800856.html
 

 
All contents Copyright © 2012-2017 Emily Patterson / Johnson and Toxin. All rights reserved.
 
Web Site and Admin Info:
Home
About
Contact
Disclaimers
Privacy Policy
Site Statistics
Site Resources
Financial Disclosure

 
Recently Posted:
2015 Johnson & Johnson US Lawsuit Update: Jump from 48,500 to 56.500
 
Johnson & Johnson Plans to Expand Healthcare Cost Crisis and Product Liability in Asia
 
Who REALLY Pays for Drug Development? US TAXPAYERS - $21 BILLION for fiscal year 2014
 
Johnson & Johnson Janssen Xarelto Marketed In Violation of FDA Regulations
 
Johnson & Johnson Destroys Thousands of Files Related to Vaginal Mesh
 
Johnson & Johnson: The Global Lawsuit Company


 
 
Most Popular:
The Ever-Growing Number of Lawsuits Against Johnson & Johnson
 
Johnson & Johnson Credo Analysis
 
Johnson & Johnson $4 Billion for DePuy Hip Harm in U.S., With Lawsuits in at Least 4 More Countries